Cilcare Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$698K
- Investors
-
12
Cilcare General Information
Description
Operator of a biotechnology platform intends to detect and treat hearing loss while reducing the risk of cognitive decline. The company offers an integrated research and development platform with expertise in minimally invasive surgery, hearing testing, histology, and proprietary clinical technology tools, enabling pharmaceutical and biotechnology companies developing hearing therapeutics to accelerate drug development.
Contact Information
Website
www.cilcare.comCorporate Office
- 378 Rue du Professeur Blayac
- Sanofi Biopark
- 34080 Montpellier
- France
Corporate Office
- 378 Rue du Professeur Blayac
- Sanofi Biopark
- 34080 Montpellier
- France
Cilcare Timeline
Cilcare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Grant | 09-Jun-2026 | $698K | Completed | Generating Revenue | ||
| 13. Secondary Transaction - Private | 01-Dec-2025 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series A) | 04-Dec-2024 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 17-May-2023 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 04-Apr-2023 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Later Stage VC | 24-Aug-2021 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 04-Jun-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 07-Aug-2017 | $2.15M | $2.54M | Completed | Generating Revenue | |
| 5. Angel (individual) | 04-Jul-2016 | $90.3K | $389K | Completed | Startup |
Cilcare Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| P2 Shares | ||||||||
| P Shares | ||||||||
| P Shares | ||||||||
| P Shares | 1,436 | $11.779590 | $65.97 | $65.97 | 1x | $65.97 | 4.64% | |
| P Shares | 5,530 | $11.779590 | $58.9 | $58.9 | 1x | $58.9 | 17.88% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cilcare Signals
Cilcare Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Regional Development Fund (Brandenburg) | Government | Minority | ||
| Aris (Private Equity) | Venture Capital | Minority | ||
| Occitanie Angels | Angel Group | Minority | ||
| Shionogi | Corporation | Minority | ||
| SPRIM Global Investments | Holding Company | Minority |
Cilcare FAQs
-
When was Cilcare founded?
Cilcare was founded in 2014.
-
Where is Cilcare headquartered?
Cilcare is headquartered in Montpellier, France.
-
What is the size of Cilcare?
Cilcare has 49 total employees.
-
What industry is Cilcare in?
Cilcare’s primary industry is Drug Discovery.
-
Is Cilcare a private or public company?
Cilcare is a Private company.
-
What is Cilcare’s current revenue?
The current revenue for Cilcare is .
-
How much funding has Cilcare raised over time?
Cilcare has raised $47M.
-
Who are Cilcare’s investors?
European Regional Development Fund (Brandenburg), Aris (Private Equity), Occitanie Angels, Shionogi, and SPRIM Global Investments are 5 of 12 investors who have invested in Cilcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process